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Abstract
Background: This study was designed to obtain an over-
view of the analytical quality of the prothrombin time, 
reported as international normalized ratio (INR) and to 
assess the variation of INR results between European lab-
oratories, the difference between Quick-type and Owren-
type methods and the effect of using local INR calibra-
tion or not. In addition, we assessed the variation in INR 
results obtained for a single donation in comparison with 
a pool of several plasmas.
Methods: A set of four different lyophilized plasma 
samples were distributed via national EQA organizations 
to participating laboratories for INR measurement.
Results: Between-laboratory variation was lower in the 
Owren group than in the Quick group (on average: 6.7% 
vs. 8.1%, respectively). Differences in the mean INR value 
between the Owren and Quick group were relatively small 
(<0.20 INR). Between-laboratory variation was lower after 
local INR calibration (CV: 6.7% vs. 8.6%). For laboratories 
performing local calibration, the between-laboratory vari-
ation was quite similar for the Owren and Quick group 
(on average: 6.5% and 6.7%, respectively). Clinically sig-
nificant differences in INR results (difference in INR > 0.5) 
were observed between different reagents. No systematic 
significant differences in the between-laboratory vari-
ation for a single-plasma sample and a pooled plasma 
sample were observed.
Conclusions: The comparability for laboratories using 
local calibration of their thromboplastin reagent is bet-
ter than for laboratories not performing local calibration. 
Implementing local calibration is strongly recommended 
for the measurement of INR.
Keywords: between-laboratory variation; international 
normalized ratio (INR); local calibration; Owren; Quick.
Introduction
Following the introduction of the vitamin K antagonist 
warfarin as a medication in 1954 [1], the use of the syn-
thetic derivative of dicoumarol has grown to the extent 
where it is one of the most widely prescribed oral anti-
coagulant drugs in the Western hemisphere. The use of 
vitamin K antagonists in oral anticoagulation is known 
to substantially reduce the incidence of thromboembolic 
events [2]. A recent report from a large-scale retrospective 
study initiated in 2008 of over 29,000 patients indicates 
that approximately four million patients are treated with 
warfarin per year in the USA [3]. Treatment with vitamin K 
antagonists is monitored by the measurement of the pro-
thrombin time (PT).
The PT was developed by Quick [4] as a screening test 
for the extrinsic (tissue) clotting system and has over time 
become a globally utilized method, particularly following 
acceptable PT standardization using the PT ratio and sub-
sequent calculation of the international normalized ratio 
(INR) [5]. Further tests were developed and designed for 
anticoagulant control, known as the Owren method [6] 
with subsequent development of a reagent named throm-
botest [7]. In the Owren method, tissue factor is combined 
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with adsorbed plasma as a source of fibrinogen and factor 
V. Furthermore, the dilution factor of the test plasma in 
Owren’s method is greater than in Quick’s method. Owren 
tests are used extensively in Scandinavian countries. It 
has been shown that there can be clinically important sig-
nificant differences in the measurement of INR between 
the Quick and Owren method [8–11].
Differences between thromboplastin reagents used 
in the determination of INR by Quick methods are known 
to affect results and may influence patient management, 
especially at higher INR levels [12].
Previous publications have noted an improvement in 
INR results after local calibration for both Quick [13] and 
Owren-type reagents [14]. It has also been shown that dif-
ferences can be minimized by local International Sensitiv-
ity Index (ISI) correction [15].
To our knowledge, a large international multicenter 
comparison of the Quick and Owren method by measur-
ing the INR in a set of control samples has never been 
performed.
Therefore, the European Committee for External 
Quality Assurance Programmes in Laboratory Medicine 
(EQALM) Working Group on Haemostasis initiated a 
project amongst their members to compare INR results, in 
European countries. EQA organizations from 10 different 
European countries participated in this project. In total, 
618 laboratories returned results, resulting in the largest 
comparative INR study so far undertaken in Europe. The 
aim of the study was (a) to compare the results from 
participants using Quick-type reagents with those from 
participants using Owren-type reagents, (b) to compare 
the results obtained after local calibration with those 
obtained by participants performing no local calibration 
and (c) to investigate the comparability of single-donor 
plasma against pooled plasma.
Materials and methods
Participating laboratories were recruited by national External Qual-
ity Assessment (EQA) programs in 10 European countries. Each labo-
ratory received a set of four different lyophilized, buffered (HEPES) 
plasmas: samples 1 and 2 with a target INR between 2.0 and 2.5 and 
samples 3 and 4 with a target INR level in the 3.0–3.5 range. Samples 1 
and 3 were single-donor plasmas, and samples 2 and 4 pooled donor 
plasmas.
The plasma pools 2 and 4  were prepared from at least 10 dif-
ferent donors. All samples were prepared by UK NEQAS for Blood 
Coagulation, Sheffield, United Kingdom.
Samples were distributed by the national EQA organizations. 
The following organizations participated in this study with the num-
ber of participants in parentheses: AFSSAPS, France (n = 105); CEQA, 
Croatia (n = 26); DEKS, Denmark (n = 63); Equalis, Sweden (n = 76); 
INSTAND, Germany (n = 27); Labquality, Finland (n = 10); NOKLUS, 
Norway (n = 72); RoEQALM, Romania (n = 15); SKML, the Netherlands 
(n = 121); WIV-ISP, Belgium (n = 103). Results had to be returned on 
standard report forms, including information on the reagent and 
equipment used and the application (or not) of local calibration. 
All reported information and results were managed centrally in the 
offices of the ECAT Foundation, Voorschoten, The Netherlands. Sta-
tistical analyses were performed with the software package SPSS 
version 19.0. Differences in between-laboratory variation were tested 
by Snedecor’s F-test, whereas differences between INR values were 
tested by Student’s t-test. The level of significance used was 0.05.
For each sample, all results were pooled together and the mean 
and standard deviation (SD) were calculated. Results deviating by 
more than three times the standard deviation (mean plus or minus 
3 SD) were identified as outliers and were not included in this study. 
The number of outliers varied between 1.8% and 2.8%. Between-lab-
oratory variation was expressed as the coefficient of variation (CV): 
CV = 100 × SD/(mean).
The Owren-type reagents used by the participants in this study 
were Owrens PT (Medirox), Nycotest PT (Axis-Shield), Thrombotest 
PT (Axis-Shield), SPA 20/50 (Stago) and Hepato Quick (Stago).
The Quick-type reagents used were PT-Fib-HS (Instrumentation 
Laboratory), PT-Fib-Recomb (Instrumentation Laboratory), Recom-
biplastin (Instrumentation Laboratory), Recombiplastin 2G (Instru-
mentation Laboratory), Thromboplastin DS (Pacific Hemostasis), 
Innovin (Siemens), Thromborel S (Siemens), Neoplastin CI (Stago), 
Neoplastin CI Plus (Stago), Neoplastin R (Stago), Technoplastin HS 
(Technoclone), Simplastin Excel S (Trinity Biotech), Simplastin HTF 
(Trinity Biotech) and Simplastin LS (Trinity Biotech).
Results
Overall results
The mean INR values (range of minimum and maximum 
reported values by the participants) for samples 1 and 2 
are 2.12 (1.59–2.69) and 2.55 (1.87–3.26), respectively. For 
samples 3 and 4, the mean INR values are 3.09 (2.01–
4.32) and 3.27 (2.40–4.20), respectively. The mean value 
of each of the samples is in or close to the intended 
INR range (see Materials and methods). Samples 1 and 
2 with lower INR values show a slightly lower between-
laboratory variation (CV%: 7.1 and 7.5%, respectively) 
than samples 3 and 4 with higher INR values (CV%: 8.7 
and 8.0%, respectively). A statistically significant dif-
ference in the between-laboratory variation can only be 
observed between plasma 1 (single-donor plasma) and 
plasma 2 (pooled plasma) (F-statistic: 1.62; p < 0.0001). 
The between-laboratory variation for the samples with an 
INR range 2.0–2.5 is lower for the single donor plasma. 
For the samples with an INR range 3.0–3.5, the between-
laboratory variation is lower for the pooled plasma. The 
results per reagent are summarized in Table 1.
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Quick and Owren method results
Approximately 40% of the participants used a PT assay 
based on the Owren principle, and 60% a test based on 
the Quick principle. A reliable comparison between these 
two assay principles is therefore possible in this study.
Table 2 compares the results obtained by the Quick 
and Owren method reagents. The mean values obtained 
by the participants using a Quick-type reagent are higher 
than those obtained by the participants using an Owren-
type reagent, although the differences are relatively small 
and not clinically relevant (<0.20 INR). For samples 1, 3 
and 4, the differences are statistically significant (p < 0.01). 
For all samples, the between-laboratory variation is statis-
tically significantly lower in the Owren group than in the 
Quick group (p < 0.05).
Local calibration
Approximately 55% of the participants performed a local 
INR calibration (Owren reagent group: 217 out of 245, 
89%; Quick reagent group: 119 out of 365, 33%), using an 
INR calibration set either of commercial origin (n = 132) 
or obtained from an EQA organization (n = 204). These 
calibration sets consist of a set of plasma samples with 
assigned INR values and are used to calibrate their local 
PT measurement system [16]. This group included six par-
ticipants carrying out a full local ISI calibration of the PT 
reagent used. Except for eight participants, who did not 
indicate whether or not they had performed a local cali-
bration, all other participants did not apply a local INR 
calibration.
Table 3 compares the results obtained with and 
without the performance of a local INR calibration, irre-
spective of the type of assay used.
The between-laboratory variation in the calibration 
group is on average 2% lower than in the non-calibration 
group. This difference is statistically significant for all 
samples (p < 0.0001). The mean INR values are lower in 
the calibration group than in the non-calibration group. 
Although the differences in these mean values are rela-
tively small and not clinically relevant (<0.15 INR), for all 
samples they are statistically significant (p < 0.001).
Table 1: Overview of the INR results (mean [CV%]) for reagents with at least 10 participants.
Reagent No Sample 1 Sample 2 Sample 3 Sample 4
Owren reagents
 Owrens PT (Medirox) 59 2.05 (4.0) 2.56 (5.1) 3.06 (4.9) 3.26 (5.5)
 Nycotest PT (Nycomed) 50 2.10 (5.7) 2.57 (7.8) 3.07 (8.1) 3.27 (7.3)
 SPA 20/50 (Stago) 99 2.04 (5.9) 2.54 (6.7) 2.90 (6.9) 3.22 (7.8)
 Hepato Quick (Stago) 26 2.08 (2.4) 2.60 (2.8) 3.03 (2.4) 3.30 (2.7)
Quick reagents
 PT-Fib-Recomb (Instrumentation Laboratory) 16 2.47 (9.3) 2.96 (9.8) 3.59 (21.2) 3.80 (11.3)
 Recombiplastin (Instrumentation Laboratory/Hemoliance) 40 2.25 (6.2) 2.65 (6.4) 3.12 (7.4) 3.49 (7.4)
 Innovin (Siemens) 104 2.11 (5.2) 2.39 (5.0) 3.09 (6.5) 3.11 (6.1)
 Thromborel S (Siemens) 55 2.16 (6.5) 2.55 (6.7) 3.03 (6.9) 3.29 (7.3)
 Neoplastin CI (Stago) 38 2.21 (4.3) 2.58 (5.4) 3.30 (4.8) 3.29 (4.9)
 Neoplastin CI Plus (Stago) 74 2.15 (3.4) 2.62 (3.8) 3.25 (4.9) 3.33 (4.5)
 Neoplastin R (Stago) 10 2.20 (5.0) 2.61 (6.1) 3.22 (7.8) 3.48 (4.6)










Quick   Owren Quick   Owren Quick   Owren Quick   Owren
Number   362   243  363   240  354   245  357   245
Mean   2.17   2.05  2.55   2.54  3.16   2.99  3.29   3.23
Minimum   1.59   1.60  1.87   1.89  2.01   2.27  2.40   2.40
Maximum  2.69   2.53  3.26   3.02  4.32   3.98  4.20   3.94
CV, %   6.9   5.8  8.2   6.7  8.9   7.0  8.5   7.4
F-statistic  1.49   1.42   1.70   1.34
p-Value   p < 0.001a   p < 0.01a   p < 0.0001a   p < 0.05a
aStatistically significant difference.
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Only small differences (<0.1 INR) were observed in the 
mean INR values between the users of commercial cali-
bration sets and those using calibration sets provided by 
EQA organizations (data not shown).
The majority of the participants in the Owren group 
(89%) performed a local INR calibration, whereas only 
one third of the participants in the Quick group (33%) did 
so. Both assay groups were evaluated as to whether or 
not local calibration had affected the between-laboratory 
variation. This evaluation is summarized in Table 4 for 
the Owren assay group and in Table 5 for the Quick assay 
group.
For the Owren assay group, the between-laboratory 
variation in the local INR calibration group is on average 
2.8% lower than in the non-calibration group. For the 
Quick assay group, this is on average 1.6%. Except for 
sample 3 for the Owren assay group, all differences are sta-
tistically significant (Owren: p <  0.002; Quick: p < 0.005).
For the Owren group, the mean INR values are lower 
in the non-calibration group, whereas for the Quick group, 
the mean INR values are lower in the calibration group. 
In both cases, the differences are relatively small, in the 
Owren group <0.20 INR and in the Quick group <0.15 INR.
In the Quick group, there are two reagents (Innovin and 
Thromborel S) with a sufficient number of results in both 
the calibration (Innovin: n = 70; Thromborel S: n = 26) and 
the non-calibration groups (Innovin: n = 34; Thromborel 
S: n = 27). This makes it possible to evaluate whether at a 
reagent level the effect of local calibration on the between-
laboratory variation can also be observed. For Innovin, the 
between-laboratory variation is CV is 0.5% (range: −1.2% to 
+0.1%) lower in the calibration group in comparison with 
the non-calibration group. For Thromborel S, the differ-
ence is 1% (range: −1.5% to −0.4%) lower. Table 6 shows 
that in almost all cases, the between-laboratory variation 
in the calibration group is lower than in the non-calibra-
tion group. These differences are not significant.
Discussion
In this study, we were able to evaluate on a large inter-
national scale using different types of samples the Quick 
and Owren INR determination as well as the effect of local 
calibration on the comparability of test results.
There were no systematically significant differences in 
the between-laboratory variation of results from samples 
derived from single-donor plasma and pooled plasma 
when all the results were evaluated together. This finding 
shows that the INR system is robust and in principle both 
types of plasma samples can be used by external quality 
assessment programs.
In this study, we found differences in three out of four 
samples between the mean INR value measured using 
Quick and Owren methods. However, these differences 
were relatively small. Differences between different test 
systems or reagents have been published previously [17–
20], but in addition to this observation, we were also able 
to demonstrate on a large scale that the between-labora-
tory variation of the Owren group results was less than the 
Table 3: Comparison of the INR results obtained with and without 












No   Yes No   Yes No   Yes No   Yes
Number   264   333  266   329  256   335  261   333
Mean   2.18   2.08  2.58   2.51  3.16   3.03  3.29   3.22
Minimum   1.59   1.71  1.87   1.89  2.01   2.27  2.40   2.62
Maximum   2.69   2.53  3.26   3.02  4.32   4.09  4.20   3.94
CV, %   7.8   5.8  8.5   6.8  8.9   7.6  9.0   6.8
F-statistic   1.87   1.62   1.75   1.83
p-Value   p < 0.0001a   p < 0.0001a   p < 0.0001a   p < 0.0001a
aStatistically significant difference.
Table 4: Comparison of the INR results obtained by the Owren assay 












No   Yes No   Yes No   Yes No   Yes
Number   26   212  27   208  27   213  27   213
Mean   2.00   2.05  2.47   2.55  2.93   2.99  3.12   3.24
Minimum   1.60   1.71  1.90   1.89  2.40   2.27  2.40   2.62
Maximum   2.18   2.53  2.74   3.02  3.22   3.98  3.44   3.94
CV, %   8.9   5.6  9.9   6.4  7.2   7.2  11.0   6.8
F-statistic   2.38   2.28   0.96   2.40
p-Value   p < 0.001a   p < 0.002a   p = 0.959   p < 0.001a
aStatistically significant difference.
Table 5: Comparison of the INR results obtained by the Quick assay 












No   Yes No   Yes No   Yes No   Yes
Number   238   121  239   121  229   122  234   120
Mean   2.19   2.13  2.60   2.45  3.20   3.09  3.34   3.19
Minimum   1.59   1.92  1.87   2.12  2.01   2.52  2.40   2.67
Maximum   2.69   2.51  3.26   2.92  4.32   4.09  4.20   3.80
CV, %   7.2   5.8  8.1   6.7  9.2   7.5  8.6   6.9
F-statistic   1.61   1.61   1.61   1.70
p-Value   p < 0.005a   p < 0.005a   p < 0.005a   p < 0.002a
aStatistically significant difference.
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between-laboratory variation of the Quick group results. 
One of the reasons could be the larger number of different 
reagents included in the Quick group (n = 14) in comparison 
with the Owren group (n = 5). This observation shows that, 
although the intention of the transformation of prothrom-
bin time results to INR results was to harmonize test results, 
this is in real laboratory practice not fully achievable with 
many different reagent and equipment combinations.
Another reason for the difference between the Quick 
and Owren group could be the fact that the majority of 
laboratories using Owren reagents had already introduced 
local INR calibration (89% vs. 33%). We therefore inves-
tigated whether local calibration might advance further 
comparability of test results between laboratories using 
either Owren or Quick reagents. There are two ways to 
perform local calibration: (a) by using a set of (lyophi-
lized) plasmas with assigned INR values (this set can be 
used for “direct” transformation of a measured PT to INR) 
or (b) by using a set of plasmas with assigned PT for an 
international reference thromboplastin. This set can be 
used for local ISI calibration of the reagent/instrument 
but MNPT must be determined separately for INR calcula-
tion [21]. In this study, we did not discriminate between 
these two calibration procedures.
Irrespective of the type of assay used, the between-
laboratory variation of participants applying local INR 
calibration was lower than the between-laboratory vari-
ation of participants not applying local INR calibration 
(Table 3).
Due to the large number of participants in the Quick 
group, it was possible to investigate the effect of local 
calibration on the between-laboratory variation of the INR 
measurement. In addition, the effect of local calibration 
was also investigated in the Owren group.
The results shown in Tables 4 and 5 indicate that in 
the absence of local calibration, the between-laboratory 
variation in the Quick group is lower than in the Owren 
group (on average: 8.3% vs. 9.3%, respectively). However, 
it should be noted that the number of participants in 
the Owren group without local calibration is relatively 
low (n = 26), which may have contributed to the higher 
between-laboratory variation for the Owren group.
When local calibration is applied, the between-lab-
oratory variation becomes comparable in the Quick and 
Owren group (on average: 6.7% vs. 6.5%, respectively). 
This difference is much lower than when the whole Quick 
group is compared to the Owren group (on average: 8.1% 
vs. 6.7%, respectively).
In this study, there were two Quick-type reagents 
(Innovin and Thromborel S) with a sufficient number of 
participants in the calibration and non-calibration groups. 
Although on the level of each individual sample the differ-
ence in between-laboratory variation between the calibra-
tion and non-calibration groups was not significant, it is 
clear that also on a reagent level the average between-lab-
oratory variation of all samples in the calibration group is 
lower than the non-calibration group (Innovin: 5.4% vs. 
5.9%; Thromborel S: 6.5% vs. 7.3%).
This finding indicates that the between-laboratory vari-
ation of INR results is similar for both the Owren and Quick 
groups after local INR calibration. However, there are still 
small differences between the Owren and Quick group in the 
average INR values of the four plasma samples. Although 
these differences are small (≤0.10 INR), they are statistically 
significant (p < 0.01), but not clinically relevant. Within the 
Quick group, larger differences in the average INR values 
were observed which may be clinically relevant (Table 1).
On the basis of our study results, we strongly recom-
mend implementing local calibration for INR measure-
ment to advance the comparability of INR results between 
different laboratories.
It is now generally accepted in laboratory medicine 
that reference materials and external quality assessment 
samples should be commutable [22]. Although the present 
study was not designed to assess the commutability of 
the four lyophilized plasma samples, it should be noted 
that large differences in INR might be caused by non-com-
mutability. For example, the mean INR determined with 
PT-Fib Recombinant was more than 10% greater than the 
mean INR with Innovin (Table 4). We cannot exclude the 
possibility that this difference is due to a lack of commuta-
bility of the test samples. Therefore, we suggest that future 
studies should be designed to assess the commutability of 
lyophilized plasma samples.













No   Yes No   Yes No   Yes No   Yes No   Yes
Innovin (Siemens)   34   70   2.15 (5.1)   2.09 (4.8)   2.41 (5.0)   2.37 (5.1)   3.13 (6.7)   3.06 (6.2)   3.15 (6.7)   3.09 (5.5)
Thromborel S (Siemens)   27   26   2.16 (6.9)   2.16 (6.5)   2.55 (7.5)   2.52 (6.0)   3.02 (7.3)   3.03 (6.3)   3.28 (7.6)   3.28 (7.0)
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In conclusion, this study has shown that the com-
parability of INR results for laboratories using local cali-
bration of their reagent is better than for laboratories not 
performing local calibration. Implementing local cali-
bration for the measurement of INR is therefore strongly 
recommended. After local calibration, the between-lab-
oratory variation of INR results is similar for both the 
Owren and the Quick groups. In addition, this study has 
shown that external quality assessment programs can 
use either single-donor plasma or pooled plasmas for 
their surveys.
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